BRCA2 protein expression in sporadic breast carcinoma with or without allelic loss of BRCA2
✍ Scribed by Dominique Bernard-Gallon; Monique Peffault De Latour; Pascale Rio; David Favy; Candan Hizel; Cécile Vissac; Yves-Jean Bignon
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- French
- Weight
- 580 KB
- Volume
- 86
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
To elucidate the cellular role of BRCA2 in sporadic breast tumors, we studied the cellular localization and the expression of BRCA2 in carcinomas presenting or not allelic loss of BRCA2. The breast tumors were first classified with or without allelic loss of BRCA2 and then immunohistochemical staining was performed on tumors and matched normal tissues using antibodies raised against BRCA2. We showed that BRCA2 is found either in the nucleus or in perinuclear compartments such as the endoplasmic reticulum and the Golgi vesicles. We have earlier demonstrated the presence of BRCA1 as an exocrine secretion in the lumen of ductules in the normal mammary gland, as well as BRCA1 and BRCA2 in milk-fat globules inside mammary-gland ductules during lactation. Here we show that BRCA2 is present within the lumina of breast ductules, indicating that BRCA2 protein may also be secreted in the mammary gland. No correlation was found in breast tumors between the expression of BRCA2 protein and allelic loss of BRCA2. Int.
📜 SIMILAR VOLUMES
## Abstract Breast cancer occurs rarely in men and risk factors for the disease include germline mutations of the __BRCA2__ gene. High frequency of allelic loss at the __BRCA2__ locus has been reported in sporadic breast tumors, but somatic mutations of __BRCA2__ are very rare. Here we report the f
## BACKGROUND. The purpose of this investigation was to elucidate the clinicopathologic characteristics of BRCA1-and BRCA2-associated hereditary breast carcinomas (HBCs) in Japanese women.
## BACKGROUND. The expression of steroid receptors is a common feature of both male and female breast carcinomas and is also one of the most important prognostic factors for patients with this disease. Steroid receptor levels in BRCA1related breast carcinoma have reportedly been low. Little data o